HealthEquity (HQY) CEO logs tax withholding sale of 12,496 shares

Rhea-AI Filing Summary

HealthEquity, Inc. insider activity: President and CEO Scott Cutler, who also serves as a director of HealthEquity, Inc. (HQY), reported a disposition of common stock. On 01/12/2026, he disposed of 12,496 shares of common stock at a price of $89.8274 per share, as shown by transaction code "F". Following this transaction, he directly beneficially owned 109,820 shares of HealthEquity common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cutler Scott

Role President and CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	12,496	$89.8274	$1.12M

Holdings After Transaction: Common Stock — 109,820 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cutler Scott

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UT 84020

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/12/2026		F		12,496	D	$89.8274	109,820	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The Power of Attorney given by Mr. Cutler was previously filed with the U.S. Securities and Exchange Commission on January 10, 2025, as an exhibit to a statement on Form 3 filed by Mr. Cutler with respect to HealthEquity, Inc. and is hereby incorporated by reference.

	/s/ Michael Newton, Attorney-in-Fact	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did HealthEquity (HQY) report for Scott Cutler?

Scott Cutler, President, CEO and director of HealthEquity, Inc., reported a disposition of 12,496 shares of common stock on 01/12/2026.

At what price were the HealthEquity (HQY) shares disposed of in this Form 4?

The 12,496 shares of HealthEquity common stock were disposed of at a price of $89.8274 per share.

How many HealthEquity (HQY) shares does Scott Cutler own after the reported transaction?

After the reported transaction, Scott Cutler beneficially owns 109,820 shares of HealthEquity common stock, held directly.

What is Scott Cutler’s role at HealthEquity (HQY)?

Scott Cutler is reported as both a director and an officer, serving as President and CEO of HealthEquity, Inc.

Is this HealthEquity (HQY) Form 4 filed for one or multiple reporting persons?

This Form 4 is indicated as being filed by one reporting person, Scott Cutler.

What type of security was involved in Scott Cutler’s HealthEquity (HQY) transaction?

The transaction involved HealthEquity, Inc. common stock as the non-derivative security.